Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1993 Aug 1;90(15):6952-6.
doi: 10.1073/pnas.90.15.6952.

Human Immunodeficiency Virus Type 1 (HIV-1) Strains Selected for Resistance Against the HIV-1-specific [2',5'-bis-O-(tert-butyldimethylsilyl)-3'-spiro- 5''-(4''-amino-1'',2''-oxathiole-2'',2''-dioxide)]-beta-D-pentofurano Syl (TSAO) Nucleoside Analogues Retain Sensitivity to HIV-1-specific Nonnucleoside Inhibitors

Affiliations
Free PMC article

Human Immunodeficiency Virus Type 1 (HIV-1) Strains Selected for Resistance Against the HIV-1-specific [2',5'-bis-O-(tert-butyldimethylsilyl)-3'-spiro- 5''-(4''-amino-1'',2''-oxathiole-2'',2''-dioxide)]-beta-D-pentofurano Syl (TSAO) Nucleoside Analogues Retain Sensitivity to HIV-1-specific Nonnucleoside Inhibitors

J Balzarini et al. Proc Natl Acad Sci U S A. .
Free PMC article

Abstract

We recently reported that a newly discovered class of nucleoside analogues--[2',5'-bis-O-(tert-butyldimethylsilyl)- 3'-spiro-5''-(4''-amino-1'',2''-oxathiole-2'',2''-dioxide)]-beta-D - pentofuranosyl derivatives of pyrimidines and purines (designated TSAO)--are highly specific inhibitors of human immunodeficiency virus type 1 (HIV-1) and targeted at the nonsubstrate binding site of HIV-1 reverse transcriptase (RT). We now find that HIV-1 strains selected for resistance against three different TSAO nucleoside derivatives retain sensitivity to the other HIV-1-specific nonnucleoside derivatives (tetrahydroimidazo[4,5,1-jk][1,4]benzodiazepin-2(1H)-one and -thione (TIBO), 1-[(2-hydroxyethoxy)methyl]-6-phenylthiothymine, nevirapine, and pyridinone L697,661, as well as to the nucleoside analogues 3'-azido-3'-deoxythymidine, ddI, ddC, and 9-(2-phosphonylmethoxyethyl)adenine. Pol gene nucleotide sequence analysis of the TSAO-resistant and -sensitive HIV-1 strains revealed a single amino acid substitution at position 138 (Glu-->Lys) in the RT of all TSAO-resistant HIV-1 strains. HIV-1 RT in which the Glu-138-->Lys substitution was introduced by site-directed mutagenesis and expressed in Escherichia coli could not be purified because of rapid degradation. However, HIV-1 RT containing the Glu-138-->Arg substitution was stable. It lost its sensitivity to the TSAO nucleosides but not to the other HIV-1-specific RT inhibitors (i.e., TIBO and pyridinone). Our findings point to a specific interaction of the 4''-amino group on the 3'-spiro-substituted ribose moiety of the TSAO nucleosides with the carboxylic acid group of glutamic acid at position 138 of HIV-1 RT.

Similar articles

See all similar articles

Cited by 21 articles

See all "Cited by" articles

References

    1. Science. 1992 Jun 26;256(5065):1783-90 - PubMed
    1. Virology. 1993 Jan;192(1):246-53 - PubMed
    1. J Med Chem. 1992 Aug 7;35(16):2988-95 - PubMed
    1. Antimicrob Agents Chemother. 1992 May;36(5):1073-80 - PubMed
    1. Science. 1984 May 4;224(4648):497-500 - PubMed

Publication types

Substances

LinkOut - more resources

Feedback